CareStart™ COVID-19 IgM/IgG Test
Manufacturer : Access Bio, USA
CareStartTM COVID-19 IgM/IgG is a lateral flow immuno-chromatographic assay for the detection of SARS-CoV-2 IgM/IgG antibodies in human blood specimens. This test differentiates IgM and IgG specific to SARS-CoV-2 in a single test within 10 minutes. CareStartTM COVID-19 IgM/IgG is manufactured by Access-bio Inc, an industry leading diagnostics business.
Fast and easy to use in a qualified CLIA setting
Detect and differentiate IgM/IgG antibody specific to SARS-CoV-2
Require a small sample volume (10 uL of whole blood, serum, or plasma)
Obtain the results in only 10 minutes
No equipment or training required
Identify and monitor individual’s previous infection history and immune response to COVID-19
Clinical performance (NIH/NCI) of 100% sensitivity and 97.5% specificity
FDA Emergency Use Authorized (EUA)
CE Certified
User Instruction
-
Add 10µl of the sample (whole blood, serum, or plasma).
2. Add 1 drop of Assay Buffer
3. Read the test results after 10 minutes.
Results Interpretation
Covid-19 Positive
Covid-19 Negative
Invalid
Order Information
| Product name | Cat No. | Units | Kit Contents |
| CareStart COVID-19 IgM/IgG Test | RCHM-02072 | 20 Tests / Kit | 20 Test devices 20 Assay buffer 20 Extraction vials and caps 20 Specimen collection swabs 1 Positive and 1 negative control swabs 1 Instructions for Use |